US Stock MarketDetailed Quotes
DSKYF DAIICHI SANKYO COMPANY LIMITED
- 35.910
- -0.700-1.91%
15min DelayClose Jul 26 16:00 ET
68.56BMarket Cap52.81P/E (TTM)
38.200High35.750Low3.13KVolume38.040Open36.610Pre Close115.33KTurnover0.00%Turnover Ratio52.81P/E (Static)1.91BShares40.35052wk High6.25P/B68.56BFloat Cap23.30652wk Low0.33Dividend TTM1.91BShs Float40.350Historical High0.92%Div YieldTTM6.69%Amplitude17.502Historical Low36.870Avg Price1Lot Size
About DAIICHI SANKYO COMPANY LIMITED Company
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Company Profile
SymbolDSKYF
Company NameDAIICHI SANKYO COMPANY LIMITED
Founded2005
CEOMr. Sunao Manabe
MarketPink Market
Employees14887
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
AddressDaiichi Sankyo Head Office Bldg, A&B,3-5-1 Nihonbashi-honcho,Chuo-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code103-8426
Phone81-3-6225-1111
Company Executives
- Name
- Position
- Salary
- Sunao Manabe
- Executive Chairman of the Board and Chief Executive Officer
- --
- Takashi Matsumoto
- Director, Managing Executive Officer, Chief Human Resources Officer and Head of Global HR
- --
- Hiroyuki Okuzawa
- Director, President and Chief Operating Officer
- --
- Takashi Fukuoka
- Director, Senior Executive Officer and Head, Global Corporate Strategy
- --
- Shoji Hirashima
- Director, Senior Executive Officer and Head, Japan Business Unit
- --
- Kazuaki Kama
- Chairman of the Board
- --
- Yasuhiro Komatsu
- Independent Director
- --
- Yo Honma
- Independent Director
- --
- Takaaki Nishii
- Independent Director
- --
- Sawako Nohara
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg